102 related articles for article (PubMed ID: 11920180)
1. Specific dose-response effects of TGF-beta1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood.
Fortunel N; Hatzfeld J; Aoustin L; Batard P; Ducos K; Monier MN; Charpentier A; Hatzfeld A
Hematol J; 2000; 1(2):126-35. PubMed ID: 11920180
[TBL] [Abstract][Full Text] [Related]
2. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
Ducos K; Panterne B; Fortunel N; Hatzfeld A; Monier MN; Hatzfeld J
J Cell Physiol; 2000 Jul; 184(1):80-5. PubMed ID: 10825236
[TBL] [Abstract][Full Text] [Related]
3. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
Fortunel N; Hatzfeld J; Kisselev S; Monier MN; Ducos K; Cardoso A; Batard P; Hatzfeld A
Stem Cells; 2000; 18(2):102-11. PubMed ID: 10742382
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
[TBL] [Abstract][Full Text] [Related]
6. [Effect of TGF-beta1 on biological characteristics of umbilical cord blood hematopoietic progenitor cells during ex-vivo expansion].
Hao SG; Sun GL; Wu WL; Wu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):20-8. PubMed ID: 14989763
[TBL] [Abstract][Full Text] [Related]
7. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
8. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
Ottmann OG; Pelus LM
J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
10. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta.
Fortunel NO; Hatzfeld JA; Monier MN; Hatzfeld A
Oncol Res; 2003; 13(6-10):445-53. PubMed ID: 12725536
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
13. Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma.
Wu JC; Livingston DH; Hauser CJ; Deitch EA; Rameshwar P
Ann Surg; 2001 Aug; 234(2):224-32. PubMed ID: 11505069
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
Lemoli RM; Fogli M; Fortuna A; Tura S
Haematologica; 1995; 80(1):5-12. PubMed ID: 7758992
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic transplant potential of unrelated cord blood: critical issues.
Kögler G; Callejas J; Hakenberg P; Enczmann J; Adams O; Däubener W; Krempe C; Göbel U; Somville T; Wernet P
J Hematother; 1996 Apr; 5(2):105-16. PubMed ID: 8723785
[TBL] [Abstract][Full Text] [Related]
16. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells.
Fortunel N; Batard P; Hatzfeld A; Monier MN; Panterne B; Lebkowski J; Hatzfeld J
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1867-75. PubMed ID: 9625749
[TBL] [Abstract][Full Text] [Related]
17. Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.
Cardoso AA; Li ML; Batard P; Hatzfeld A; Brown EL; Levesque JP; Sookdeo H; Panterne B; Sansilvestri P; Clark SC
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8707-11. PubMed ID: 7690969
[TBL] [Abstract][Full Text] [Related]
18. The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells.
Ducos K; Hatzfeld A; Héron A; Fortunel N; Kisselev S; Héron C; Monier MN; Hatzfeld J
Gene Ther; 2000 Oct; 7(20):1790-4. PubMed ID: 11083502
[TBL] [Abstract][Full Text] [Related]
19. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation.
Batard P; Monier MN; Fortunel N; Ducos K; Sansilvestri-Morel P; Phan T; Hatzfeld A; Hatzfeld JA
J Cell Sci; 2000 Feb; 113 ( Pt 3)():383-90. PubMed ID: 10639326
[TBL] [Abstract][Full Text] [Related]
20. [Effects of anti-TGF-beta1 monoclonal antibody on in vitro expansion of cord blood CD34(+) cells].
Li Y; Liu FQ; Wang JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1546-50. PubMed ID: 20030944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
